52 Week HighNatco Pharma has hit a 52wk high of Rs 779.90 on NSE
52 Week HighNatco Pharma has hit a 52wk high of Rs 735.00 on NSE
AnnouncementsNatco Pharma: EGM on Nov 14, 2013
52 Week HighNatco Pharma has hit a 52wk high of Rs 728.10 on BSE
AnnouncementsNatco Pharma: Outcome of board meeting
52 Week HighNatco Pharma has hit a 52wk high of Rs 724.90 on NSE
AnnouncementsNatco Pharma clarifies on increase in volume
52 Week HighNatco Pharma has hit a 52wk high of Rs 684.00 on NSE
|Company Name||Last Price||%
|Dr Reddys Labs||2450.35||-0.56||2545.00||1764.00||41,680.39|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,606.65 crore.The company has reported a consolidated sales of Rs 179.22 crore and a Net Profit of Rs 24.26 crore for the quarter ended Sep 2013.
The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Nitin Jagannath Deshmukh - Director.
It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.
Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.